ABOUT GSNBD-2027
The Leading Platform for Neurology & Brain Disorders Research
Three days of science, collaboration and clinical insight in Paris, France — October 18–20, 2027.
A MESSAGE FROM THE COMMITTEE
Welcome to GSNBD-2027
On behalf of the Organizing Committee, we invite all participants from every part of the world to attend GSNBD-2027, held October 18–20, 2027 in Paris, France. GSNBD-2027 is the leading meeting dedicated to Neurosurgeons and Neurology researchers, bringing together the global conversation on “Emerging Perspectives in Neurology and Brain Disorders.”
GSNBD-2027 happens to be an annual meeting of Neurosurgeons and Neurology professionals exploring the future of neurosurgery and neurological disorders — in terms of collaboration, structures, organizational development and the advancement of the field.
We cordially welcome researchers, academicians, business delegates, scholars and students to participate on this global platform and showcase their research work. GSNBD-2027 is a consortium of the scientific fraternity, scholars, educationists, industry leaders and entrepreneurs collaborating to resolve challenges across neurology and brain disorders.
Foundational & Cutting-Edge Research, Together
GSNBD-2027 covers a wide range of subjects in general neurology, brain disorders and emerging research fields.
Why GSNBD-2027 Exists
Share Knowledge
A platform for presenting peer-reviewed research across the full spectrum of neurology and brain disorders.
Build Collaboration
Connecting neurosurgeons, researchers, academicians and industry leaders to resolve shared challenges.
Drive Patient Outcomes
Translating emerging research into clinical procedures that improve care and save lives.
THE PROGRAM
An Expanded Scientific Program
GSNBD-2027 has expanded upon previous years’ meetings, opening up several more categories for its scientific sessions — making this meeting bigger and even more exciting than its predecessors.
The program involves discussion of specific topics in neurology and brain disorders, including dementia, epilepsy, migraine, multiple sclerosis, neuroinfectious disease, stroke, psychiatry, psychology and traumatic brain injury.